Close Menu

There's another social networking web site for scientists, and this one, called Epernicus, claims to already have "enabled thousands of scientists at close to 1,200 institutions in 57 countries to find other researchers with specific skill sets, averting the time-consuming, labor intensive processes of tracking down scientists who have information that they need," says a press release. "Think of us as a Facebook or LinkedIn for scientists but with a concrete purpose," says co-founder Mikhail Shapiro.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.